Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan Sabbagh

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Alzheimer'S Research & Therapy|May 11, 2021
Aducanumab produced a clinically meaningful benefit in association with amyloid loweringJeffrey Cummings, Paul Aisen, Cynthia Lemere, et al.
Gerontology|November 18, 2016
Instrumented Trail-Making Task to Differentiate Persons with No Cognitive Impairment, Amnestic Mild Cognitive Impairment, and Alzheimer Disease: A Proof of Concept StudyHe Zhou, Marwan Sabbagh, Rachel Wyman, et al.
Journal of Molecular Neuroscience : MN|September 23, 2003
A position paper: based on observational data indicating an increased rate of altered blood chemistry requiring withdrawal from the Alzheimer's Disease Cholesterol-Lowering Treatment Trial (ADCLT)D Larry Sparks, Jean Lopez, Don Connor, et al.
CNS Neuroscience & Therapeutics|March 7, 2013
High-dose donepezil (23 mg/day) for the treatment of moderate and severe Alzheimer's disease: drug profile and clinical guidelinesJeffrey L Cummings, David Geldmacher, Martin Farlow, et al.
Journal of Alzheimer'S Disease Reports|May 13, 2021
Does Informant-Based Reporting of Cognitive Decline Correlate with Age-Adjusted Hippocampal Volume in Mild Cognitive Impairment and Alzheimer's Disease?Marwan Sabbagh, Justin Miller, Stephen Jones, et al.
Acta Neurologica Scandinavica|January 25, 2019
A prospective study on gait dominant normal pressure hydrocephalusMelissa Song, Abraham Lieberman, Terry Fife, et al.
Gerontology|May 14, 2016
The Impact of Mild Cognitive Impairment on Gait and Balance: A Systematic Review and Meta-Analysis of Studies Using Instrumented AssessmentLindsay Bahureksa, Bijan Najafi, Ahlam Saleh, et al.
Neurology and Therapy|July 29, 2022
Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert PanelRajesh Pahwa, Stuart H Isaacson, Gary W Small, et al.
International Journal of Psychiatry in Clinical Practice|May 16, 2022
Unmet needs in the diagnosis and treatment of Parkinson's disease psychosis and dementia-related psychosisMarwan Sabbagh, Gary W Small, Stuart H Isaacson, et al.
Neurology and Therapy|July 6, 2023
Correction to: Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert PanelRajesh Pahwa, Stuart H Isaacson, Gary W Small, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Alzheimer'S Research & Therapy|May 11, 2021
Aducanumab produced a clinically meaningful benefit in association with amyloid loweringJeffrey Cummings, Paul Aisen, Cynthia Lemere, et al.
Gerontology|November 18, 2016
Instrumented Trail-Making Task to Differentiate Persons with No Cognitive Impairment, Amnestic Mild Cognitive Impairment, and Alzheimer Disease: A Proof of Concept StudyHe Zhou, Marwan Sabbagh, Rachel Wyman, et al.
Journal of Molecular Neuroscience : MN|September 23, 2003
A position paper: based on observational data indicating an increased rate of altered blood chemistry requiring withdrawal from the Alzheimer's Disease Cholesterol-Lowering Treatment Trial (ADCLT)D Larry Sparks, Jean Lopez, Don Connor, et al.
CNS Neuroscience & Therapeutics|March 7, 2013
High-dose donepezil (23 mg/day) for the treatment of moderate and severe Alzheimer's disease: drug profile and clinical guidelinesJeffrey L Cummings, David Geldmacher, Martin Farlow, et al.
Journal of Alzheimer'S Disease Reports|May 13, 2021
Does Informant-Based Reporting of Cognitive Decline Correlate with Age-Adjusted Hippocampal Volume in Mild Cognitive Impairment and Alzheimer's Disease?Marwan Sabbagh, Justin Miller, Stephen Jones, et al.
Acta Neurologica Scandinavica|January 25, 2019
A prospective study on gait dominant normal pressure hydrocephalusMelissa Song, Abraham Lieberman, Terry Fife, et al.
Gerontology|May 14, 2016
The Impact of Mild Cognitive Impairment on Gait and Balance: A Systematic Review and Meta-Analysis of Studies Using Instrumented AssessmentLindsay Bahureksa, Bijan Najafi, Ahlam Saleh, et al.
Neurology and Therapy|July 29, 2022
Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert PanelRajesh Pahwa, Stuart H Isaacson, Gary W Small, et al.
International Journal of Psychiatry in Clinical Practice|May 16, 2022
Unmet needs in the diagnosis and treatment of Parkinson's disease psychosis and dementia-related psychosisMarwan Sabbagh, Gary W Small, Stuart H Isaacson, et al.
Neurology and Therapy|July 6, 2023
Correction to: Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert PanelRajesh Pahwa, Stuart H Isaacson, Gary W Small, et al.
Pageof 10